Related Experiment Video
Updated: May 30, 2025

09:45
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
8.3K
Exploring ferroptosis and miRNAs: implications for cancer modulation and therapy
Mobarakeh Ajam-Hosseini1, Sadegh Babashah2
1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, P.O. Box: 14115-154, Tehran, Iran.
Molecular and Cellular Biochemistry
|January 27, 2025
Summary
Ferroptosis, a cell death linked to cancer, is regulated by microRNAs (miRNAs). Exosomal miRNAs show promise as biomarkers and therapeutic targets for managing ferroptosis in cancer pathology.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ferroptosis is an iron-dependent cell death pathway involving lipid ROS accumulation and mitochondrial changes.
- Ferroptosis is implicated in various diseases, particularly cancer, driving research into therapeutic strategies.
- MicroRNAs (miRNAs) are key regulators of ferroptosis, influencing genes in iron metabolism and lipid peroxidation.
Purpose of the Study:
- To review the role of miRNAs, especially exosomal miRNAs, in ferroptosis.
- To explore the implications of exosomal miRNAs in cancer pathology.
- To provide insights into potential therapeutic approaches targeting miRNA-mediated ferroptosis.
Main Methods:
- Literature review of studies on miRNAs, exosomal miRNAs, and ferroptosis.
- Analysis of molecular mechanisms underlying miRNA regulation of ferroptosis.
- Examination of exosomal miRNA functions as biomarkers and therapeutic agents.
Main Results:
- Exosomal miRNAs act as messengers, delivering regulatory molecules to target cells.
- miRNAs modulate ferroptosis by affecting critical genes in iron metabolism and lipid peroxidation pathways.
- Exosomal miRNAs exhibit dynamic expression patterns, making them potential cancer biomarkers.
Conclusions:
- miRNAs, particularly exosomal miRNAs, play a significant role in ferroptosis.
- Exosomal miRNAs offer potential as biomarkers for cancer diagnosis and prognosis.
- Targeting exosomal miRNAs presents a promising avenue for novel cancer therapeutic strategies.
Related Concept Videos
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K

